| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GALD.SW - | BUY | 5,825 @ 94.5073 | 550,505 | The ETF bought 5825 new shares of GALD.SW (). The shares were bought for an average price of 94.5073 compared to the previous average buy price of 98.7076. This is -4.3% lower than average price of previous purchases of GALD.SW. |
| BIM.PA - BioMerieux | HOLD | 0 @ 112.6 | 0 | |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ 42.76 | 0 | |
| ZEAL.CO - | HOLD | 0 @ 80.696 | 0 | |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ 50.4 | 0 | |
| SRT3.DE - Sartorius AG | HOLD | 0 @ 239.7 | 0 | |
| SOBI.ST - | HOLD | 0 @ 25.8891 | 0 | |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ 193.75 | 0 | |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ 52.95 | 0 | |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ 54.6 | 0 | |
| RO.SW - | HOLD | 0 @ 334.694 | 0 | |
| IPN.PA - Ipsen SA | HOLD | 0 @ 109.6 | 0 | |
| HIK.L - | HOLD | 0 @ 24.0331 | 0 | |
| DEMANT.CO - | HOLD | 0 @ 33.7261 | 0 | |
| GRF.MC - Grifols SA | HOLD | 0 @ 9.24 | 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ 20.15 | 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ 98.06 | 0 | |
| COLO-B.CO - | HOLD | 0 @ 97.425 | 0 | |
| QIA.DE - QIAGEN NV | HOLD | 0 @ 36.235 | 0 | |
| HLN.L - Haleon PLC | HOLD | 0 @ 4.64091 | 0 | |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ 13.0179 | 0 | |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ 17.8698 | 0 | |
| LONN.SW - | HOLD | 0 @ 562.61 | 0 | |
| ALC.SW - | HOLD | 0 @ 80.4056 | 0 | |
| ARGX.BR - Argenx SE | HOLD | 0 @ 534.8 | 0 | |
| UCB.BR - UCB SA | HOLD | 0 @ 180.6 | 0 | |
| BAYN.DE - Bayer AG | HOLD | 0 @ 22.9 | 0 | |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ 24.19 | 0 | |
| MRK.DE - Merck KGaA | HOLD | 0 @ 134.4 | 0 | |
| SDZ.SW - | HOLD | 0 @ 38.1942 | 0 | |
| SOON.SW - | HOLD | 0 @ 282.554 | 0 | |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ 51.24 | 0 | |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ 38.94 | 0 | |
| GMAB.CO - | HOLD | 0 @ 183.242 | 0 | |
| STMN.SW - | HOLD | 0 @ 116.352 | 0 | |
| EL.PA - EssilorLuxottica SA | SELL | -152 @ 262.6 | -39,915 | The ETF sold 152 shares of EL.PA on 2025-03-13. The shares were previously bought for an average price of 247.299. The EssilorLuxottica SA shares were sold for 6.2% higher than average price of previous purchases. This sale made a profit of 2,326 The average price that the ETF previously sold EL.PA share for is so the ETF has sold 152 shares on 2025-03-13 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -584 @ 106.22 | -62,032 | The ETF sold 584 shares of SAN.PA on 2025-03-13. The shares were previously bought for an average price of 97.4636. The Sanofi SA shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of 5,114 The average price that the ETF previously sold SAN.PA share for is so the ETF has sold 584 shares on 2025-03-13 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -990 @ 100.876 | -99,867 | The ETF sold 990 shares of NOVN.SW on 2025-03-13. The shares were previously bought for an average price of 97.1807. The shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of 3,658 The average price that the ETF previously sold NOVN.SW share for is so the ETF has sold 990 shares on 2025-03-13 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -351 @ 315.44 | -110,719 | The ETF sold 351 shares of ROG.SW on 2025-03-13. The shares were previously bought for an average price of 286.695. The shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of 10,089 The average price that the ETF previously sold ROG.SW share for is so the ETF has sold 351 shares on 2025-03-13 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -784 @ 141.647 | -111,051 | The ETF sold 784 shares of AZN.L on 2025-03-13. The shares were previously bought for an average price of 130.691. The AstraZeneca PLC shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of 8,590 The average price that the ETF previously sold AZN.L share for is so the ETF has sold 784 shares on 2025-03-13 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -1,621 @ 70.3744 | -114,077 | The ETF sold 1621 shares of NOVO-B.CO on 2025-03-13. The shares were previously bought for an average price of 77.8236. The Novo Nordisk A/S shares were sold for -9.6% lower than average price of previous purchases. This resulted in an overall loss of 12,075 The average price that the ETF previously sold NOVO-B.CO share for is so the ETF has sold 1621 shares on 2025-03-13 at a higher price than the previous selling average. |